BSE filing, NSE: VRAJ. Summary written from the filing by ALFA Finder's alert engine.
Vraj Iron & Steel Ltd: key numbers
- Share price
- ₹125.20
- Market cap
- ₹412.9 Cr
- Revenue (annual)
- ₹587.9 Cr
- Net profit (annual)
- ₹32.00 Cr
- P/E (TTM)
- 11.5×Sector 16.7×
- Promoter holding
- 74.95%+0.00% QoQ
- FII holding
- 0.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vraj Iron & Steel Ltd
All →Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel transferred 396,000 MVK Industries shares to promoter Gopal Sponge for Rs 4.55 Crore. The sale was completed on October 28, 2026.
- Value
- ₹4.55 Cr
Vraj Iron & Steel Capacity Expansion
Vraj Iron and Steel received fresh Terms of Reference for its Greenfield Steel Plant project in Raipur. The project includes a 60 MW power plant and brick manufacturing capacity.
- power plant capacity
- 60.0 MW
Vraj Iron & Steel Regulatory Approval
Vraj Iron and Steel received a fresh ToR from MoEF&CC for its greenfield Raipur steel plant. The multi-component facility includes DRI kilns, induction furnaces and rolling mills.
- induction furnace steel capacity
- 412500 TPA
Vraj Iron & Steel Other Announcement
Vraj Iron And Steel Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel Limited sold its entire stake in MVK Industries Private Limited to its promoter for Rs. 4.55 Crore. The proceeds will fund expansion.
- Value
- ₹4.55 Cr
- From
- Gopal Sponge and Power Private Limited
Vraj Iron & Steel Annual General Meeting
Vraj Iron and Steel Limited concluded its 22nd Annual General Meeting on September 12, 2026. The meeting discussed financial adoption and director re-appointments.
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.